Table 1.

NSF casesa

Patient (Age, Race, Gender)Study Performed (Contrast, Dosage, Date of Exposure)Onset of SymptomsTreatmentCourse
1. 62, black, maleMRI left foot (MV, 20 ml, 3/17/05)4/25/2005NoneProgressive, fatal
2. 70, white, maleFistulogram ×3 (OS, 50 ml 12/2/05; 30 ml, 12/6/05; 30 ml, 1/2/06)2/8/2006Steroids, physical therapyProgressive, fatal
3. 49, white, femaleMRI brain (OS, 125 ml, 1/16/06)3/23/2006NoneStable
  • a MV, Magnevist (Gadopentetate Dimeglumine, Berlex Laboratories, Montville, NJ); NSF, nephrogenic systemic fibrosis; OS, Omniscan (Gadodiamide, Amersham, Buckinghamshire, UK).